BI Asset Management Fondsmaeglerselskab A S Purchases 17,428 Shares of CVS Health Co. (NYSE:CVS)

BI Asset Management Fondsmaeglerselskab A S lifted its position in CVS Health Co. (NYSE:CVS - Free Report) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 473,067 shares of the pharmacy operator's stock after purchasing an additional 17,428 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in CVS Health were worth $21,236,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in CVS. Dodge & Cox boosted its position in shares of CVS Health by 11.2% during the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock valued at $3,147,054,000 after acquiring an additional 7,075,209 shares during the last quarter. Capital World Investors grew its stake in CVS Health by 26.6% in the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after buying an additional 12,819,148 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of CVS Health by 2.6% in the 4th quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator's stock worth $1,211,582,000 after buying an additional 689,867 shares during the last quarter. Capital International Investors lifted its holdings in shares of CVS Health by 4.8% during the 4th quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock worth $1,196,989,000 after acquiring an additional 1,212,126 shares during the last quarter. Finally, Pzena Investment Management LLC grew its position in CVS Health by 49.3% in the fourth quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after acquiring an additional 6,475,271 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In other news, SVP James David Clark sold 7,513 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at $556,941.90. The trade was a 47.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Michael F. Mahoney acquired 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.22% of the company's stock.

CVS Health Trading Up 0.1 %

CVS Health stock traded up $0.10 during mid-day trading on Thursday, reaching $65.67. 3,584,767 shares of the company traded hands, compared to its average volume of 11,810,116. The firm's 50 day moving average price is $66.48 and its 200 day moving average price is $58.82. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $71.45. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The firm has a market capitalization of $82.79 billion, a price-to-earnings ratio of 17.95, a P/E/G ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be issued a $0.665 dividend. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.05%. CVS Health's dividend payout ratio (DPR) is 72.68%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on CVS shares. Robert W. Baird raised their price target on CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Leerink Partnrs upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. Cantor Fitzgerald upgraded shares of CVS Health from a "neutral" rating to an "overweight" rating in a research report on Wednesday, February 12th. Finally, Piper Sandler upped their price target on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Four research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average target price of $71.83.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.